Biogen Long Term Debt vs Deferred Long Term Liab Analysis

BIIB Stock

USD 159.83 2.14 1.36%

Biogen financial indicator trend analysis is way more than just evaluating Biogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biogen Inc is a good investment. Please check the relationship between Biogen Long Term Debt and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biogen Inc Long Term Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have very week relationship.

The correlation between Biogen's Long Term Debt and Deferred Long Term Liab is 0.24. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Biogen Inc, assuming nothing else is changed. The correlation between historical values of Biogen's Long Term Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Biogen Inc are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Long Term Debt i.e., Biogen's Long Term Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.24

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Long Term Debt

Long-term debt is a debt that Biogen Inc has held for over one year. Long-term debt appears on Biogen Inc balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Biogen Inc balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Biogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

At present, Biogen's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 19.32, whereas Tax Provision is forecasted to decline to about 128.5 M.

	2021	2022	2023	2024 (projected)
Gross Profit	8.9B	7.9B	7.3B	3.9B
Total Revenue	11.0B	10.2B	9.8B	10.3B

Gross Profit Total Revenue

Biogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments	Common Stock	Short Term Debt
Total Assets		0.92	0.95	0.95	0.94	0.96	0.85	0.99	0.63	0.99	-0.57	0.61	0.96	-0.74	0.94	0.49	-0.82	0.96	0.86	0.93	0.59	0.89	-0.8	0.3	-0.8	0.4
Short Long Term Debt Total	0.92		0.86	0.86	0.76	0.89	0.96	0.9	0.58	0.9	-0.72	0.59	0.88	-0.62	0.98	0.42	-0.92	0.97	0.8	0.87	0.45	0.83	-0.63	0.33	-0.63	0.31
Other Current Liab	0.95	0.86		0.94	0.88	0.88	0.77	0.94	0.66	0.93	-0.58	0.7	0.9	-0.7	0.91	0.48	-0.81	0.94	0.7	0.92	0.47	0.83	-0.75	0.46	-0.75	0.4
Total Current Liabilities	0.95	0.86	0.94		0.85	0.92	0.75	0.91	0.72	0.92	-0.53	0.67	0.91	-0.74	0.89	0.34	-0.79	0.94	0.75	0.9	0.43	0.94	-0.74	0.34	-0.74	0.53
Total Stockholder Equity	0.94	0.76	0.88	0.85		0.89	0.68	0.94	0.56	0.93	-0.37	0.52	0.9	-0.73	0.78	0.52	-0.63	0.82	0.86	0.87	0.7	0.79	-0.85	0.18	-0.85	0.3
Property Plant And Equipment Net	0.96	0.89	0.88	0.92	0.89		0.82	0.92	0.59	0.96	-0.5	0.54	0.97	-0.78	0.92	0.44	-0.75	0.94	0.88	0.87	0.5	0.95	-0.78	0.21	-0.78	0.46
Net Debt	0.85	0.96	0.77	0.75	0.68	0.82		0.83	0.33	0.86	-0.7	0.38	0.82	-0.5	0.94	0.36	-0.86	0.91	0.81	0.73	0.54	0.71	-0.56	0.22	-0.56	0.25
Retained Earnings	0.99	0.9	0.94	0.91	0.94	0.92	0.83		0.63	0.97	-0.62	0.6	0.94	-0.66	0.92	0.46	-0.85	0.94	0.85	0.93	0.61	0.83	-0.73	0.28	-0.73	0.34
Cash	0.63	0.58	0.66	0.72	0.56	0.59	0.33	0.63		0.51	-0.41	0.9	0.59	-0.64	0.59	0.37	-0.6	0.64	0.3	0.83	-0.07	0.72	-0.47	0.52	-0.47	0.34
Non Current Assets Total	0.99	0.9	0.93	0.92	0.93	0.96	0.86	0.97	0.51		-0.55	0.49	0.95	-0.69	0.93	0.44	-0.78	0.95	0.91	0.86	0.67	0.86	-0.78	0.18	-0.78	0.41
Non Currrent Assets Other	-0.57	-0.72	-0.58	-0.53	-0.37	-0.5	-0.7	-0.62	-0.41	-0.55		-0.38	-0.54	0.14	-0.72	-0.13	0.87	-0.68	-0.46	-0.55	-0.26	-0.47	0.06	-0.2	0.06	-0.19
Cash And Short Term Investments	0.61	0.59	0.7	0.67	0.52	0.54	0.38	0.6	0.9	0.49	-0.38		0.52	-0.6	0.61	0.48	-0.6	0.64	0.18	0.84	-0.14	0.62	-0.55	0.83	-0.55	0.36
Net Receivables	0.96	0.88	0.9	0.91	0.9	0.97	0.82	0.94	0.59	0.95	-0.54	0.52		-0.75	0.91	0.4	-0.79	0.93	0.87	0.88	0.53	0.9	-0.74	0.18	-0.74	0.35
Common Stock Shares Outstanding	-0.74	-0.62	-0.7	-0.74	-0.73	-0.78	-0.5	-0.66	-0.64	-0.69	0.14	-0.6	-0.75		-0.64	-0.45	0.42	-0.68	-0.56	-0.75	-0.26	-0.8	0.85	-0.36	0.85	-0.3
Non Current Liabilities Total	0.94	0.98	0.91	0.89	0.78	0.92	0.94	0.92	0.59	0.93	-0.72	0.61	0.91	-0.64		0.44	-0.92	0.99	0.79	0.88	0.43	0.85	-0.65	0.37	-0.65	0.41
Other Current Assets	0.49	0.42	0.48	0.34	0.52	0.44	0.36	0.46	0.37	0.44	-0.13	0.48	0.4	-0.45	0.44		-0.25	0.42	0.38	0.54	0.24	0.36	-0.6	0.4	-0.6	0.01
Other Stockholder Equity	-0.82	-0.92	-0.81	-0.79	-0.63	-0.75	-0.86	-0.85	-0.6	-0.78	0.87	-0.6	-0.79	0.42	-0.92	-0.25		-0.9	-0.64	-0.82	-0.32	-0.71	0.37	-0.37	0.37	-0.35
Total Liab	0.96	0.97	0.94	0.94	0.82	0.94	0.91	0.94	0.64	0.95	-0.68	0.64	0.93	-0.68	0.99	0.42	-0.9		0.79	0.91	0.44	0.89	-0.69	0.37	-0.69	0.45
Property Plant And Equipment Gross	0.86	0.8	0.7	0.75	0.86	0.88	0.81	0.85	0.3	0.91	-0.46	0.18	0.87	-0.56	0.79	0.38	-0.64	0.79		0.67	0.78	0.76	-0.65	-0.17	-0.65	0.28
Total Current Assets	0.93	0.87	0.92	0.9	0.87	0.87	0.73	0.93	0.83	0.86	-0.55	0.84	0.88	-0.75	0.88	0.54	-0.82	0.91	0.67		0.35	0.85	-0.76	0.53	-0.76	0.34
Intangible Assets	0.59	0.45	0.47	0.43	0.7	0.5	0.54	0.61	-0.07	0.67	-0.26	-0.14	0.53	-0.26	0.43	0.24	-0.32	0.44	0.78	0.35		0.32	-0.53	-0.35	-0.53	-0.06
Accounts Payable	0.89	0.83	0.83	0.94	0.79	0.95	0.71	0.83	0.72	0.86	-0.47	0.62	0.9	-0.8	0.85	0.36	-0.71	0.89	0.76	0.85	0.32		-0.71	0.25	-0.71	0.52
Common Stock Total Equity	-0.8	-0.63	-0.75	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.74	0.85	-0.65	-0.6	0.37	-0.69	-0.65	-0.76	-0.53	-0.71		-0.36	1.0	-0.23
Short Term Investments	0.3	0.33	0.46	0.34	0.18	0.21	0.22	0.28	0.52	0.18	-0.2	0.83	0.18	-0.36	0.37	0.4	-0.37	0.37	-0.17	0.53	-0.35	0.25	-0.36		-0.36	0.27
Common Stock	-0.8	-0.63	-0.75	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.74	0.85	-0.65	-0.6	0.37	-0.69	-0.65	-0.76	-0.53	-0.71	1.0	-0.36		-0.23
Short Term Debt	0.4	0.31	0.4	0.53	0.3	0.46	0.25	0.34	0.34	0.41	-0.19	0.36	0.35	-0.3	0.41	0.01	-0.35	0.45	0.28	0.34	-0.06	0.52	-0.23	0.27	-0.23

Click cells to compare fundamentals

Biogen Account Relationship Matchups

Biogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Short Long Term Debt Total	6.4B	7.8B	7.6B	6.6B	7.3B	7.7B
Other Current Liab	3.4B	3.1B	2.4B	2.4B	2.5B	2.7B
Total Current Liabilities	4.9B	3.7B	4.3B	3.3B	3.4B	3.6B
Total Stockholder Equity	13.3B	10.7B	11.0B	13.4B	14.8B	15.5B
Property Plant And Equipment Net	3.7B	3.8B	3.8B	3.7B	3.7B	3.9B
Net Debt	3.5B	6.5B	5.3B	3.2B	6.3B	6.6B
Retained Earnings	16.5B	14.0B	13.9B	16.5B	17.6B	18.5B
Cash	2.9B	1.3B	2.3B	3.4B	1.0B	723.1M
Non Current Assets Total	18.9B	17.7B	16.0B	14.8B	20.0B	21.0B
Non Currrent Assets Other	(3.2B)	(1.4B)	1.9B	1.5B	284.3M	270.1M
Cash And Short Term Investments	4.5B	2.6B	3.8B	4.9B	1.0B	1.5B
Net Receivables	1.9B	2.3B	2.0B	2.1B	2.1B	2.2B
Common Stock Shares Outstanding	187.4M	161.3M	149.6M	146M	145.6M	283.0M
Liabilities And Stockholders Equity	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Non Current Liabilities Total	9.0B	10.2B	8.6B	7.9B	8.6B	9.0B
Other Current Assets	1.2B	881.1M	740.8M	1.4B	1.2B	1.2B
Other Stockholder Equity	(3.0B)	(3.0B)	(2.9B)	(2.9B)	(2.7B)	(2.5B)
Total Liab	13.9B	13.9B	12.9B	11.2B	12.0B	12.6B
Property Plant And Equipment Gross	3.7B	3.8B	3.8B	3.7B	6.1B	6.4B
Total Current Assets	8.4B	6.9B	7.9B	9.8B	6.9B	7.2B
Accumulated Other Comprehensive Income	(135.2M)	(299M)	(106.7M)	(164.9M)	(153.7M)	(146.0M)
Intangible Assets	3.5B	3.1B	2.2B	1.9B	8.4B	8.8B
Accounts Payable	530.8M	454.9M	589.2M	491.5M	403.3M	423.5M
Short Term Investments	2.3B	1.6B	1.3B	1.5B	1.5B	0.0
Inventory	804.2M	1.1B	1.4B	1.3B	2.5B	2.7B
Other Liab	4.2B	2.4B	2.0B	1.3B	1.5B	969.6M
Other Assets	3.2B	4.2B	3.4B	1.7B	1.9B	2.0B
Long Term Debt	4.5B	7.4B	6.3B	6.3B	6.8B	7.1B
Property Plant Equipment	3.2B	3.4B	3.4B	3.3B	3.8B	2.1B
Good Will	5.8B	5.8B	5.8B	5.7B	6.2B	3.2B
Net Tangible Assets	4.1B	1.9B	2.9B	5.8B	6.7B	4.1B
Noncontrolling Interest In Consolidated Entity	(4.1M)	(14.2M)	63.5M	(9.5M)	(8.6M)	(8.1M)
Retained Earnings Total Equity	16.5B	14.0B	13.9B	16.5B	18.9B	11.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.02)

Earnings Share

11.06

Revenue Per Share

66.122

Quarterly Revenue Growth

(0.03)

Return On Assets

0.0499

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biogen Long Term Debt vs Deferred Long Term Liab Analysis

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Long Term Debt

Deferred Long Term Liab

Biogen fundamental ratios Correlations

Biogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biogen fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Retained Earnings	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Total Liab	+ 0.97	Short Long Term Debt Total

Other Stockholder Equity	- 0.92	Non Current Liabilities Total
Other Stockholder Equity	- 0.92	Short Long Term Debt Total
Total Liab	- 0.9	Other Stockholder Equity
Other Stockholder Equity	- 0.86	Net Debt
Other Stockholder Equity	- 0.85	Retained Earnings
Common Stock	- 0.85	Total Stockholder Equity